Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

著者: Bruce Cree, Jeffrey L. Bennett, Ho Jin Kim, Brian G. Weinshenker, Sean J Pittock, Dean M. Wingerchuk, Kazuo Fujihara, Friedemann Paul, Gary Cutter, Romain Marignier, Ari Green, Orhan Aktaş, Hans‐Peter Hartung, Fred Lublin, Jörn Drappa, Gerard Barron, Soraya Madani, John N. Ratchford, Dewei She, Daniel Cimbora, Eliezer Katz - The Lancet 2019 被引用: 717